| LDO Home | General | Kidney | Liver | Marrow | Experiences | Buddies | Hall of Fame | Calendar | Contact Us |

Author Topic: CVD, Diabetes Ups Hospitalization Risk for Living Kidney Donors  (Read 698 times)

0 Members and 1 Guest are viewing this topic.

Offline Clark

  • Administrator
  • Top 10 Poster!
  • *****
  • Posts: 3,012
  • Please give the gift of life!
    • Living Donors Online!
https://www.renalandurologynews.com/home/conference-highlights/american-transplant-congress/cvd-diabetes-ups-hospitalization-risk-for-living-kidney-donors/

CVD, Diabetes Ups Hospitalization Risk for Living Kidney Donors
Natasha Persaud

Living kidney donors may have increased risks for end-stage kidney disease (ESKD) following nephrectomy. New study findings presented at the 2023 American Transplant Congress in San Diego, California, add that living kidney donors with diabetes or cardiovascular disease — risk factors for ESKD and its sequelae — are more likely to be hospitalized after donation.
Amy Chang, MD, of Johns Hopkins University School of Medicine in Baltimore, Maryland, and colleagues studied post-donation hospitalization records from 2265 living kidney donors who underwent nephrectomy from 1968 to 2019. Median age at donation was 46 years.
Hospitalization within a median 7 years affected 42% of donors. The most common reasons for hospitalization were surgery (59%), cardiovascular causes (16%), and urologic problems (6%). The investigators predicted that up to half of living kidney donors would eventually experience hospitalization following nephrectomy.
After adjusting for clinical characteristics, cardiovascular and diabetes history in the donor were significantly associated with 1.5- and 2.2-fold increased odds of hospitalization, the investigators reported. Hospitalization was not associated with patient sex, smoking history, education level, or income.
Hospitalization of living kidney donors may be “a sentinel event” for adverse outcomes, according to Dr Chang and colleagues.
“Since diabetes is the leading cause of [ESKD] in this population and cardiovascular disease is the leading cause of death in an [ESKD] population, hospitalization in donors presents a crucial opportunity to avert the most adverse long-term outcomes described in this population.”
Reference
Chang A, Phung A, Mehta S, et al. All-cause hospitalization among live kidney donors after nephrectomy. Presented at: ATC 2023; June 3-7, San Diego, California. Abstract 480.
Unrelated directed kidney donor in 2003, recipient and I both well.
618 time blood and platelet donor since 1976 and still giving!
Elected to the OPTN/UNOS Boards of Directors & Executive, Kidney Transplantation, and Ad Hoc Public Solicitation of Organ Donors Committees, 2005-2011
Proud grandpa!

 

 Subscribe in a reader



Copyright © International Association of Living Organ Donors, Inc. All Rights Reserved